Bayer's Indian crop-science unit; sells crop-protection chemicals and DEKALB hybrid corn seeds to farmers.
Price
Market Cap
Sector
Commodities
Rank
| Line item | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 | FY26 |
|---|---|---|---|---|---|---|---|---|
| LiabilitiesEquity Capital | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 45 |
| Reserves | 2.5k | 2.5k | 2.5k | 2.7k | 2.8k | 2.8k | 3.1k | 2.9k |
| Borrowings | 2 | 26 | 86 | 74 | 47 | 105 | 102 | 82 |
| Other Liabilities | 1.3k | 1.7k | 1.7k | 1.9k | 1.7k | 2.3k | 2.0k | 2.7k |
| Total Liabilities | 3.8k | 4.2k | 4.4k | 4.7k | 4.6k | 5.2k | 5.2k | 5.7k |
| AssetsFixed Assets | 468 | 425 | 468 | 462 | 414 | 470 | 585 | 458 |
| CWIP | 56 | 76 | 98 | 109 | 119 | 119 | 9 | 127 |
| Investments | 41 | 52 | 38 | 41 | 54 | 35 | 41 | 57 |
| Other Assets | 3.3k | 3.7k | 3.7k | 4.1k | 4.0k | 4.6k | 4.6k | 5.1k |
| Total Assets | 3.8k | 4.2k | 4.4k | 4.7k | 4.6k | 5.2k | 5.2k | 5.7k |
| Line item | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| ActivitiesCash from Operating | 433 | 666 | 687 | 216 | 609 | 952 | 262 | 1.1k |
| Cash from Investing | -113 | -29 | 7 | 64 | 83 | 0 | 86 | 72 |
| Cash from Financing | -158 | -148 | -556 | -703 | -613 | -656 | -619 | -624 |
| SummaryCapital Expenditure | — | — | — | — | — | — | — | — |
| Free Cash Flow | 378 | 638 | 656 | 168 | 537 | 912 | 222 | 1.0k |
| FCF Margin | — | — | — | — | — | — | — | — |
The Earnings Per Share over the last 12 months.
Your assumption of the company's expected yearly EPS growth (e.g., 6 for 6%).
Pre-filled with the lower of median (32.0×) and current (27.5×) PE — the conservative anchor.
The annualized return you aim to achieve. We solve for the price that delivers it, then compare to today's price.
At 1.3% growth and a 28× exit, ₹4218 only delivers your return if you pay ₹1,892. The price is currently baking in 17% growth.
EPS grows 1.3%/yr for 5 years, then fades to 6% over 2, exits at 28×.
| Year | Growth | EPS (₹) |
|---|---|---|
| FY27 | 1.3% | 155.34 |
| FY28 | 1.3% | 157.36 |
| FY29 | 1.3% | 159.41 |
| FY30 | 1.3% | 161.48 |
| FY31 | 1.3% | 163.58 |
| FY32 | 3.7% ·fade | 169.55 |
| FY33 | 6.0% ·fade | 179.72 |
Methodology: we discount normalized net profit as a proxy for owner earnings (an earnings-power approximation — not full free cash flow). Terminal growth is capped at 6% (≈ nominal GDP) regardless of the required return. This is an analytical tool, not investment advice.
Guides on how to read this kind of business and the numbers that matter.